Sensor of molecular imbalance in metabolic disorder: Determination of molecular behavior wired in disease utilizing metabolomics

<p>Metabolic disorders are known as one of the largest obesity epidemics and associated with health-related problems such as cardiovascular disease, diabetes, hypertension and hyperlipidemias in the US. Obesity related to an imbalance of metabolism from environmental stressors impacting metabo...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Michael Chernichaw (लेखक), Yoon Ju Lee (लेखक), Diane E Heck (लेखक), Hong Duck Kim (लेखक)
स्वरूप: पुस्तक
प्रकाशित: Journal of Addiction Medicine and Therapeutic Science - Peertechz Publications, 2020-07-20.
विषय:
ऑनलाइन पहुंच:Connect to this object online.
टैग: टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

MARC

LEADER 00000 am a22000003u 4500
001 peertech__10_17352_2455-3484_000040
042 |a dc 
100 1 0 |a Michael Chernichaw  |e author 
700 1 0 |a  Yoon Ju Lee  |e author 
700 1 0 |a  Diane E Heck  |e author 
700 1 0 |a Hong Duck Kim  |e author 
245 0 0 |a Sensor of molecular imbalance in metabolic disorder: Determination of molecular behavior wired in disease utilizing metabolomics 
260 |b Journal of Addiction Medicine and Therapeutic Science - Peertechz Publications,   |c 2020-07-20. 
520 |a <p>Metabolic disorders are known as one of the largest obesity epidemics and associated with health-related problems such as cardiovascular disease, diabetes, hypertension and hyperlipidemias in the US. Obesity related to an imbalance of metabolism from environmental stressors impacting metabolic rate, reflects the multi-dimensional molecular network. Obesity is also associated with the genetic predisposition of a build-up of adipose tissue dynamics, which is unable to properly undergo lipolysis and breakdown at the tissue level, or it can be a hormonal issue, where the patient is producing too much ghrelin or diminishing supply of leptin. Omics, a detection platform for macromolecules (i.e., DNA, RNA, and protein level), can be developed for use in many different types of illnesses based on the pathophysiology behind the ailment or disease, including obesity. Personalized care focused on molecule assessment can help decrease the need for synthetic insulin, increase the body's own ability to use it's already producing pancreatic beta cells of insulin, and decrease the likelihood of other comorbidities from progressing by adapting part of Omics metabolomics. Metabolomics is more advantageous than determining the pathologic structure of molecular behavior in ghrelin and leptin. In the future, metabolomics has strong potential to be considered as an alternative preventive tool to fight against obesity, hyperlipidemia, or secondary health complications, including cardiovascular and cancer mortality.</p> 
540 |a Copyright © Michael Chernichaw et al. 
546 |a en 
655 7 |a Review Article  |2 local 
856 4 1 |u https://doi.org/10.17352/2455-3484.000040  |z Connect to this object online.